Basics Recursion Pharmaceuticals, Inc. IPO Date: April 16, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.78B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 3.96% Avg Daily Range (30 D): $0.19 | 4.08% Avg Daily Range (90 D): $0.30 | 4.74% Institutional Daily Volume Avg Daily Volume: 4.89M Avg Daily Volume (30 D): 21.13M Avg Daily Volume (90 D): 23.23M Trade Size Avg Trade Size (Sh.): 171 Avg Trade Size (Sh.) (30 D): 334 Avg Trade Size (Sh.) (90 D): 266 Institutional Trades Total Inst.Trades: 2,039 Avg Inst. Trade: $2.29M Avg Inst. Trade (30 D): $1.51M Avg Inst. Trade (90 D): $1.77M Avg Inst. Trade Volume: .26M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.71M Avg Closing Trade (30 D): $2.72M Avg Closing Trade (90 D): $4.12M Avg Closing Volume: 419.37K     News May 27, 2025 @ 12:05 AM 3 Monster Stocks to Hold for the Next 10 Years Source: James Brumley May 12, 2025 @ 8:18 AM Should You Buy This Beaten-Down Artificial Intelli... Source: Prosper Junior Bakiny May 9, 2025 @ 9:17 PM Why Recursion Pharmaceuticals Stock Plummeted 24% ... Source: Johnny Rice May 4, 2025 @ 4:45 PM Preliminary Phase 1b/2 Data for REC-4881 in Famili... Source: Recursion Apr 25, 2025 @ 9:10 PM Why Biohaven Stock Plummeted by More Than 15% Toda... Source: Eric Volkman Financials   TTM Q4 2024 FY 2024 Basic EPS $-.5 $-.57 $-1.69 Diluted EPS $-.5 $-.57 $-1.69 Revenue $ 14.75M $ 4.55M $ 58.84M Gross Profit $ -7.08M $ -8.25M $ 13.6M Net Income / Loss $ -202.49M $ -178.91M $ -463.66M Operating Income / Loss $ -191.37M $ -183.77M $ -479M Cost of Revenue $ 21.83M $ 12.79M $ 45.24M Net Cash Flow $ -93.87M $ 167.19M $ 201.6M PE Ratio